ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Áø·á°ú ¾È³»
[¹®ÀÇÀüÈ] 1577-9966
Áø·á°ú¸¦ ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Áø·á°úÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
°£¼¾ÅÍ
-
[SCI]
Reply
Lee YS, Hyun MH, Kim JH, Yeon JE, Byun KS
/ Reply
/ 2019;70:447-8.
/ 201907
-
[SCI]
Reply
Lee YS, Hyun MH, Yim SY, Kim JH, Yeon JE, Byun KS.
/ Reply
/ 201907
-
[SCI]
Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms
Lee YS, Seo YS, Kim JH, et al.
/ Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms
/ 2018;12:94-101.
/ 201807
-
[SCI]
CX(3)CR1 differentiates F4/80(low) monocytes into pro-inflammatory F4/80(high) macrophages in the liver.
Lee YS, Kim MH, Yi HS, et al
/ CX(3)CR1 differentiates F4/80(low) monocytes into pro-inflammatory F4/80(high) macrophages in the liver.
/ 2018;8:15076.
/ 201807
-
[SCI]
Loss of toll-like receptor 3 aggravates hepatic inflammation but ameliorates steatosis in mice.
Lee YS, Kim DY, Kim TJ, et al.
/ Loss of toll-like receptor 3 aggravates hepatic inflammation but ameliorates steatosis in mice.
/ 2018;497:957-62.
/ 201807